Medical Device News

Medline Unveils New CLABSI Prevention Solution

Vascular Access Health Solution features a holistic approach to patient safety and clinical support

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Medline announced today the launch of its Vascular Access Health Solution, a new central line-associated bloodstream infection (CLABSI) prevention solution driven by human factors-based strategies throughout the entire life of the line, from insertion to removal.

The holistic solution is the latest innovation born out of Medline’s existing vascular access offerings, enhancing practices and pioneering new approaches, as the needs of health systems across the nation continue to evolve.

The need for standardization in the vascular access health space is significant, especially with CLABSI incidents rapidly increasing since the onset of the pandemic. According to the Centers of Disease Control and Prevention (CDC), CLABSIs have increased about 24% since the onset of the pandemic. The CDC also reports the largest increase in CLABSI occurred in Q4 of 2020, at 47% across all location types.

About 70% of CLABSI infections are avoidable through following consistent, evidence-based practices for prevention1. Developed by Medline’s team of vascular access health experts and clinicians, the Vascular Access Health Solution incorporates best practice guidance, education and training, and a system of products, leveraging custom insertion and maintenance bundling to better support clinicians.

“Our goal is to partner with health systems in their journey to reaching zero CLABSIs. Medline’s Vascular Access Health Solution is a strategy that identifies opportunities to streamline workflows and create intuitively designed products and kits to prevent human error, keeping in mind the many variables impacting clinicians’ work environments,” said Christine Dorshorst, vice president, critical care sales at Medline. “With constant changes, labor shortages and the increase of traveling nurses, it’s important to implement solutions that make it easier for clinicians to do their jobs.”

Bundling is one of the strongest defenses to minimize human error and maintain safety consistency, with studies showing that CLABSIs decreased significantly from 6.4 per 1000 catheter-days to 2.5 per 1000 catheter-days after bundling products2. The Vascular Access Health Solution approach customizes bundles with a system of products that intuitively guides clinicians through central line insertions and sterile dressing changes, resulting in maximized procedure safety and clinical workflow efficiency.

“Medline has a unique approach to bundling where we customize the system of products based on health systems’ already established policies and protocols,” said Dorshorst. “This integrative approach is much more effective than changing policies around products.”

In conjunction with the program, Medline formed a specialty vascular access salesforce to zero in on CLABSI reduction. The newly formed specialty team focuses on where touchpoints can be minimized and practices can be standardized by design, to create a more sustainable process. The Vascular Access Health Solution is also powered by personalized clinical workforce training and education, leveraging unit-based safety champion ideologies and engagement techniques – created by clinicians, for clinicians.

“Education and training is something that should be constantly reinforced, as the environments in which our clinicians work are constantly evolving,” said Donna Matocha, DNP, manager of clinical resources at Medline. “Getting back-to-the-basics is essential. When clinicians feel prepared, they feel empowered. This is what ultimately results in better care and patient outcomes, and a happier staff.”

To learn more about Medline’s Vascular Access Health Solution and clinically-driven infection prevention strategies, visit

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure

Ann Decker, VP of Reimbursement for Valencia Technologies, stated, "The cumulative effect of the proposed 2025 continuation of APC assignment 5464, the improved ASC payment rate, and the recognition of ITNS as a minimally invasive OAB treatment option in the recently updated guidelines by the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU), underscores that the eCoin ITNS system will have a strong reimbursement pathway throughout 2025 and beyond.